z-logo
open-access-imgOpen Access
Clinical Evolution of AmpC-Mediated Ceftazidime-Avibactam and Cefiderocol Resistance in Enterobacter cloacae Complex Following Exposure to Cefepime
Author(s) -
Ryan K. Shields,
Alina Iovleva,
Ellen G Kline,
Akito Kawai,
Christi L. McElheny,
Yohei Doi
Publication year - 2020
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciaa355
Subject(s) - cefepime , enterobacter cloacae , ceftazidime/avibactam , cephalosporin , ceftazidime , microbiology and biotechnology , biology , enterobacter , siderophore , avibactam , polymyxin , chemistry , enterobacteriaceae , bacteria , antibiotics , pseudomonas aeruginosa , biochemistry , genetics , escherichia coli , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom